logo

For the Inventor, By the Inventor

Seoul, South Korea

Jw Pharmaceutical Corporation


USPTO Granted Patents = 13

% Expired Patents = 7.7



Forward Citations = 1

Loading Chart...
Loading Chart...

47 inventors (with patents filed for the assignee):

goldMedal Do Kyu Pyun (4 out of 4 patents)

silverMedal Kyoung Jin Oo (4 out of 4 patents)

bronzeMedal Do-Kyu Pyun (2 out of 2 patents)

4.  Suk Kyeong Lee (1 out of 8 patents)

5.  Sang-Hak Lee (1 out of 2 patents)

6.  Won-Kyoung Lee (1 out of 1 patent)

7.  Su-Ha Park (1 out of 1 patent)

8.  Kyoung-Jin O (1 out of 1 patent)

9.  Sang-A Lee (1 out of 1 patent)

10.  Ji-Hyun Jung (1 out of 12 patents)

11.  Yong Soo Bae (1 out of 4 patents)

12.  Kab Sig Kim (1 out of 3 patents)

13.  Joo-Young Cha (1 out of 1 patent)

14.  Kwan-Hoo Lee (1 out of 1 patent)

15.  Ji-Eun Jung (1 out of 3 patents)


13 patents:

1. 12612405 - Crystalline form of 1-(8-Bromopyrido[2,3-E][1,2,4]triazolo[4,3-a]pyrazin-4-Yl)-Nmethylazetidin-3-amine hydrogen sulfate monohydrate (2026-04-28),
2. 12583852 - Heterocycle derivative (2026-03-24),
3. 12497410 - Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compound (2025-12-16),
4. 12103938 - Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compound (2024-10-01),
5. 12030895 - Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compound (2024-07-09),
6. 11866448 - Method for preparing heterocyclic derivative compound, composition containing same compound, and hydrate of same compound (2024-01-09),
7. 11633409 - Solid preparation comprising dutasteride and method for preparing same (2023-04-25),
8. 9879038 - Salt of tenofovir disoproxil (2018-01-30),
9. 9840506 - Crystal of doripenem, and preparation method therefor (2017-12-12),
10. 9393201 - Oxaliplatin nanoparticles and method for preparing same (2016-07-19),
11. 9353119 - Composition for preventing and treating non-small cell lung cancer, containing pyrazino-triazine derivatives (2016-05-31),
12. 8940739 - Compound of a reverse-turn mimetic and a production method and use therefor (2015-01-27),
13. 8623348 - Interferon-α (IFN-α) fused proteins comprising IFN-α and a cytoplasmic transduction peptide (CTP) (2014-01-07),
Company Overview
Jw Pharmaceutical Corporation is a prominent South Korean company specializing in the development and manufacturing of pharmaceuticals and biopharmaceuticals. The organization focuses on innovative drug formulations and therapeutic solutions across various medical domains, including oncology, cardiology, and infectious diseases. With a commitment to enhancing healthcare outcomes, Jw Pharmaceutical leverages advanced research methodologies and technology to address unmet medical needs, contributing significantly to the global pharmaceutical landscape.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

13 Patents

#318 in Seoul

#876 in South Korea

#45,039 in the World

Seoul, KR
Seoul, South Korea

Jw Pharmaceutical Corporation

Forward Citations = 1

47 inventors:

goldMedal Do Kyu Pyun (4 out of 4 patents)

silverMedal Kyoung Jin Oo (4 out of 4 patents)

bronzeMedal Do-Kyu Pyun (2 out of 2 patents)

4.  Suk Kyeong Lee (1 out of 8 patents)

5.  Sang-Hak Lee (1 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Jw Pharmaceutical Corporation. Retrieved from https://idiyas.com/company/jw-pharmaceutical

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…